Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?

To: Adrian Wu who wrote (2178)	7/27/1998 11:33:00 AM
From: Scott H. Davis	Respond to of 4676

Adrian, don't bother appologizing for the length. I appreciated (at least as much as I could grasp) and enjoyed it. As a clinical analyst specializing in Rx, I have a little background, but am profoundly out of your league. Yet I enjoy the challenge of learning about anti-sense, rational drug design & the treatment possibilities. Scott

To: Adrian Wu who wrote (2178)	7/29/1998 10:14:00 AM
From: DELT1970	Read Replies (1) \| Respond to of 4676

Adrian, have you seen in the science the antisense involvement of Antivirals (AVII), now called AVI Biopharma? Their work is not as far along in the clinic, but I've heard they are exploring collaborations with ISIP. They are bring an interesting cancer vaccine to Phase III, but I'm looking for validation on their antisense technology. Thanks, George